BridgeMD
New treatment option for Hematopoietic and Lymphatic System Neoplasm
Official title Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
ClinicalTrials.gov ID: NCT07290543
What this study is testing
- What it's testing
- This clinical trial tests how well a web based toolkit works to improve cancer related emotional distress and anxiety in rural older cancer survivors. Rural older adults with cancer-related distress are particularly vulnerable to poorer mental health and cancer-related outcomes including increased difficulties identifying symptoms of anxiety, a reduced likelihood of knowing when to access mental health services, and a higher likelihood of having poorly managed CRD, even after receiving a psychosocial referral.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- AIM 1: Invited by a member of the study team
- AIM 1: In the following or related field:
- Healthcare professionals (physicians, nurses, pharmacists, etc.)
- Patient advocates and representatives
- Researchers in healthcare or technology fields
You likely can't join if
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the...
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent
See the full eligibility criteria
- AIM 1: Invited by a member of the study team
- AIM 1: In the following or related field:
- Healthcare professionals (physicians, nurses, pharmacists, etc.)
- Patient advocates and representatives
- Researchers in healthcare or technology fields
- Healthcare administrators and managers
- AIM 1: Must be over 18 years old
- AIM 1: English-speaking
- AIM 1: Willing and able to provide informed consent
- AIM 2 (RURAL OLDER CANCER SURVIVORS): A rural resident based on the Health Resources \& Services Administration (HRSA) rural analyzer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report of diagnosis with any cancer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report posttreatment (i.e., completion of curative intent therapy including surgery, chemotherapy, molecularly targeted, and endocrine therapy)
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Have access to a computer, a smartphone, or a tablet computer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Aged \> 65 years old
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Assessed as having Cancer and Treatment Distress scale (CTXD) scores \> 0.85 at screening
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Have a caregiver willing to participate
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Non-institutionalized
- AIM 2 (RURAL OLDER CANCER SURVIVORS): English proficient
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Willing and able to provide informed consent
- AIM 2 (CAREGIVER): An identified informal caregiver of an eligible ROCS (caregivers include, but are not limited to, a child, partner, or friend; caregivers can reside in a rural or urban area and may or may not live...
- AIM 2 (CAREGIVER): Have internet access
- AIM 2 (CAREGIVER): ≥ 18 years old
- AIM 2 (CAREGIVER): Non-institutionalized
- AIM 2 (CAREGIVER): English proficient
- AIM 2 (CAREGIVER): Willing and able to provide informed consent
- AIM 3 (FINAL WORKSHOP): Includes providers, medical and practice managers, patient care coordinators, and medical health technologists
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the body of literature that reports increased distress associated with...
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.